ofloxacin and s 1743

ofloxacin has been researched along with s 1743 in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (55.00)	29.6817
2010's	8 (40.00)	24.3611
2020's	1 (5.00)	2.80

Authors

Authors	Studies
Consolazio, A; Crispino, P; Iacopini, F; Nardi, F; Palladini, D; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M	1
Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F	1
Cammarota, G; Candelli, M; Cazzato, A; Finizio, R; Gabrielli, M; Gasbarrini, A; Gasbarrini, G; Lauritano, EC; Nista, EC; Ojetti, V; Santoro, M; Zocco, MA	1
Capodicasa, S; Cappello, G; Coraggio, D; Grossi, L; Marzio, L	1
Cammarota, G; Candelli, M; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Spada, C; Zocco, MA	1
Hassoun, A; Ibrahim, F	1
But, D; Chan, AO; Chan, CK; Chan, P; Cheung, TK; Chu, KM; Fung, J; Hsu, A; Hung, I; Wong, BC; Yee, YK; Yuen, MF	1
Di Caro, S; Franceschi, F; Gasbarrini, A; La Rocca, E; Mariani, A; Masci, E; Raimondo, D; Testoni, A; Thompson, F	1
Chang, LL; Chen, A; Hsu, PI; Hu, HM; Jan, CM; Kuo, CH; Kuo, FC; Li, CJ; Tsai, PY; Wang, SW; Wang, WM; Weng, BC; Wu, DC; Wu, IC; Yu, FJ	1
de Boer, WA; Janssen, MJ; Schrauwen, RW	1
But, D; Chan, CK; Chan, FS; Chan, P; Cheung, TK; Chu, KM; Gu, Q; Hsu, A; Hung, IF; Leung, S; Seto, WK; Tong, TS; Wong, BC; Wong, SY	1
Cristofari, F; De Francesco, V; Hassan, C; Manes, G; Scaccianoce, G; Zullo, A	1
Chang, JJ; Chang, LC; Chen, LW; Chien, RN; Fang, KM	1
Li, Y; Pan, X; Qian, B; Qiu, Y; Shi, R; Tang, Q; Yao, L; Zhang, G	1
Chang, CY; Chen, CC; Chen, MJ; Fang, YJ; Lee, JY; Lin, JT; Liou, JM; Sheng, WH; Wang, HP; Wu, MS	1
Chiu, YC; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Tai, WC; Wu, DC; Wu, KL	1
Emer, O; Kadayifci, A; Kantarcioglu, M; Ozcan, A; Polat, Z; Uygun, A	1
Compare, D; Federico, A; Gravina, AG; Iovene, MR; Loguercio, C; Marmo, R; Miranda, A; Nardone, G; Pilloni, PA; Ricciardiello, L; Rocco, A; Romano, M	1
Chang, KC; Chiou, SS; Chiu, KW; Chiu, YC; Chou, YP; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Tai, WC; Wu, DC; Wu, KL	1
He, XJ; Jiang, CS; Li, DZ; Liu, G; Wang, W; Zeng, XP	1

Trials

16 trial(s) available for ofloxacin and s 1743

Article	Year
One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:8 Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Patient Compliance; Treatment Outcome	2005
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity. Helicobacter, 2006, Volume: 11, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2006
Rifaximin-based regimens for eradication of Helicobacter pylori: a pilot study. Digestive diseases (Basel, Switzerland), 2006, Volume: 24, Issue:1-2 Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pilot Projects; Rifamycins; Rifaximin; Treatment Outcome	2006
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. The American journal of gastroenterology, 2006, Volume: 101, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2006
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 2007, Oct-01, Volume: 26, Issue:7 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Treatment Outcome	2007
Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009, Volume: 41, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Salvage Therapy; Young Adult	2009
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. The Journal of antimicrobial chemotherapy, 2009, Volume: 63, Issue:5 Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline; Treatment Outcome; Young Adult	2009
Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Helicobacter, 2009, Volume: 14, Issue:6 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin	2009
Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study. International journal of clinical practice, 2010, Volume: 64, Issue:11 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome	2010
Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Ch Clinical therapeutics, 2010, Volume: 32, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Rabeprazole	2010
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:8 Topics: Adult; Aged; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Breath Tests; Cytochrome P-450 CYP2C19; DNA Gyrase; Drug Monitoring; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome; Urea	2011
Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori. The American journal of the medical sciences, 2011, Volume: 342, Issue:3 Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome	2011
Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. European journal of internal medicine, 2012, Volume: 23, Issue:2 Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Treatment Outcome; Young Adult	2012
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology, 2012, Volume: 143, Issue:1 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Tinidazole; Treatment Outcome; Young Adult	2012
Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori. Helicobacter, 2012, Volume: 17, Issue:3 Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Taiwan	2012
Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China. Digestive diseases and sciences, 2022, Volume: 67, Issue:1 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; China; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Proton Pump Inhibitors; Treatment Outcome	2022

Other Studies

4 other study(ies) available for ofloxacin and s 1743

Article	Year
Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole. Helicobacter, 2006, Volume: 11, Issue:4 Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Breath Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Treatment Outcome; Urease	2006
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis. The American journal of geriatric pharmacotherapy, 2007, Volume: 5, Issue:1 Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin	2007
Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication. The Netherlands journal of medicine, 2009, Volume: 67, Issue:3 Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors	2009
Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice. Journal of gastrointestinal and liver diseases : JGLD, 2010, Volume: 19, Issue:2 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Time Factors; Treatment Failure	2010